⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARWR News
Arrowhead Research Corporation
Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsight
globenewswire.com
AZN
NVS
ABBV
BMY
GILD
REGN
VRTX
BIIB
JNJ
MRK
ARWR
TAK
VERA
Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight
globenewswire.com
IMVT
ROIV
MRK
NVS
REGN
UCB
JNJ
ARGX
AMGN
VIR
IPHA
ARWR
APLS
CABA
Arrowhead Pharmaceuticals Presents New Positive Clinical Cardiometabolic Data at the 94th European Atherosclerosis Society (EAS) Congress
businesswire.com
ARWR
Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA
globenewswire.com
CDXS
CRSP
ARWR
WVE
Dementia Associated With Alzheimer's Disease Market Research Report 2026: Overview of Over 80 Companies and More Than 100 Pipeline Drugs
globenewswire.com
MRK
ARWR
Oligonucleotides Clinical Trial Drug Development Pipeline Expands with Contributions from 200+ Key Companies | DelveInsight
globenewswire.com
IONS
ALNY
NVS
BIIB
ARWR
SLN
WVE
VNDA
NSP
TCRT
AMX
CDIO
SRPT
VIR
BNTX
ARCT
GSK
PFE
Wall Street's Cardiac Bet: Where Diagnostics Meet the Money
prnewswire.com
BBIO
BMY
ARWR
AMGN
Form 8-K
sec.gov
ARWR
Arrowhead Pharmaceuticals Reports Fiscal 2026 Second Quarter Results
businesswire.com
ARWR
Arrowhead Pharmaceuticals Receives TGA Approval of REDEMPLO® (plozasiran) in Australia, Expanding Global Access for Patients with Familial Chylomicronemia Syndrome (FCS)
businesswire.com
ARWR